Trial intelligence / Profile preview

Effect of fenofibrate in the treatment of neonatal jaundice

IRCT20201209049660N1Phase 3Completed

Sponsor
Hormozgan University of Medical Sciences
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of fenofibrate in jaundice, sponsored by Hormozgan University of Medical Sciences. Started Jul 2019; status: completed.

02

Drugs

fenofibrate
03

Conditions

jaundice

Beyond the preview

Go deeper on IRCT20201209049660N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201209049660N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call